Oxytocin in cesarean-sections. What's new?

  • Yamaguchi E
  • Siaulys M
  • Torres M
N/ACitations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

© 2015 Sociedade Brasileira de Anestesiologia. Oxytocin is the uterotonic agent of choice in the prevention and treatment of postpartum uterine atony. Nevertheless, there is no consensus on the optimal dose and rate for use in cesarean sections. The use of high bolus doses (e.g., 10 IU of oxytocin) can determine deleterious cardiovascular changes for the patient, especially in situations of hypovolemia or low cardiac reserve. Furthermore, high doses of oxytocin for prolonged periods may lead to desensitization of oxytocin receptors in myometrium, resulting in clinical inefficiency.

Cite

CITATION STYLE

APA

Yamaguchi, E. T., Siaulys, M. M., & Torres, M. L. A. (2016). Oxytocin in cesarean-sections. What’s new? Brazilian Journal of Anesthesiology (English Edition), 66(4), 402–407. https://doi.org/10.1016/j.bjane.2014.11.015

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free